Cells lacking vinculin survive after detachment because they phosphorylate ERK.
After serum withdrawal, detachment from a substrate, or pro-apoptotic drug treatment, cells lacking vinculin were compared with wild-type cells. The cells lacking vinculin showed greater paxillin–FAK interaction, an increase in ERK phosphorylation, and reduced apoptosis.
The reduction in apoptosis (and increase in migration rates) could be reversed by ERK pathway inhibitors. This is reminiscent of the behavior of many cancer cell lines, which lack vinculin...
The Rockefeller University Press
2004
The Rockefeller University Press
2004
You do not currently have access to this content.
